Newly released data from Fact.MR’s analysis shows that global demand for flow cytometry enjoyed significant growth, reaching US$ 4.7 Bn as of 2020. As per the report, the market is poised to reach US$ 5.3 Bn in 2021, growing at a staggering 11.4% until 2025 to reach US$ 8.1 Bn. By 2031, the market is expected to reach US$ 12.5 Bn, registering more than 2x growth across the 2021-2031 forecast period.
Key Points Addressed in Flow Cytometry Industry Analysis
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Flow Cytometry and How to Navigate
- Recommendation on Key Winning Strategies
Know More Details About the Report
Market projections for flow cytometry from 2016-2020 compared to 2021-2031
According to Fact.MR, market research and competitive intelligence provider, from 2016 to 2020, the global market for flow cytometry has grown at a CAGR of almost 8% to reach US$ 4.7 Bn. Extensive uptake for pharmaceutical & drug discovery and diagnostics have typically influenced historical growth.
As the COVID-19 pandemic raged, pharmaceutical companies were intensively pooling their resources in order to develop potent drug and vaccine formulations, a trend which sustained market demand for flow cytometry throughout 2020. Researchers leveraged flow cytometry to characterize the type of T cells involved in the immune response to COVID-19.
Future expansion prospects will largely be driven by increasing scope of immunology and oncology research. Researchers are increasingly using flow cytometry to qualitatively and quantitatively analyze peripheral blood cells to predict immunotherapy outcomes. Based on these trends, Fact.MR expects the market to surge at a CAGR of 9% from 2021 to 2031.
How has COVID-19 Spurred Flow Cytometry Demand?
A global pandemic resulting from the spread of the acute respiratory syndrome coronavirus was seen all over the globe. The disease claimed more than 1.6 million lives globally in a year involving 71 million cases. There were cases reported by 220 countries, territories, and areas all over the world. The WHO emphasized the need to develop vaccines against the virus to the battle spread of the disease.
Researchers carried out PCR (RT-PCR) and blood antibody tests to detect COVID-19. Additionally, researchers developed another test procedure that played an important role in improving the COVID-19 testing capabilities, allowing countries to better combat SARS/COV-2. Flow cytometry was suggested as an alternative way to check for SARS-CoV-2 as new research.
The analysis of single cells or particles was carried out by flow cytometry across many different scientific disciplines. It involves exposing particles to lasers and measuring visible light scattering and or fluorescence parameters as a result. The testing facility was designed to process an estimated 2,000 tests per day using one set of equipment, providing an efficient, effective, and reliable method of testing.
Avail customized purchase options for your needs
How will Advanced Cancer Research Aid in the Growth of Flow Cytometry?
Scientists are increasingly expecting that stem cell research, immuno-oncology, and other promising treatments will improve healthcare outcomes as demand for these therapies grows. To gain deeper insights into biology, researchers increasingly ask for more advanced cytometry techniques with enhanced multiplexing capabilities.
As researchers combine therapeutic targets with drugs in the preliminary work of drug development, it could help break down the biological effects between different individuals so that the effect mechanism could be revealed.
The use of flow cytometry enables researchers to conduct comprehensive and quantitative analyses of the tumor's immune system and peripheral blood in order to predict immunotherapy success rates and help create more effective approaches to immunotherapy.
Why has the Flow Cytometry Market in North America Grown so Rapidly?
A high level of demand exists in North American markets for flow cytometry devices. Rapid technological advancements has contributed to an increase in market valuation. As chronic diseases are becoming more prevalent, research and technology in cell sorting have increased the demand for flow cytometry in these markets.
For instance, Sysmex Corporation launched flow cytometry XF-1600 in North American markets. On June 17th, 2020, the firm launched the PS-10 sample preparation system that automates sample preparation and offers a range of analyte-specific options through Sysmex in the US.
The growing understanding of immunologic forces regulating systemic diseases, as well as the development of molecular diagnostics, monoclonal antibodies, lasers, and IT, will have a profound impact on flow cytometry and hematology in the North American markets. The region is expected to account for over 1/3rd revenue until 2031.
What are the Growth Prospects for the Market in Asia?
Asia promises to exhibit a robust expansion trajectory, clocking a staggering 14% CAGR from 2020 to 2025. Improvements in healthcare infrastructure, particularly across India and China, are prompting global pharmaceutical companies to invest in the regional flow cytometry industry.
Furthermore, surging incidences of hematological and immunological diseases are also widening growth prospects. A study published in 2019 established that autoimmune diseases incidence have increased manifold, with 75% of those affected are women. Hence, flow cytometry to prevent further deterioration is inclining across the region.
An Adaptive Approach to Modern-day Research Needs
What is the Scope for Flow Cytometry Software in the Forthcoming Decade?
As technology advances, the demand for software is on the rise in the medical industry. The increasing demand for advanced software that can be used with these devices is due to the increasing desire to view the cells and examine them simultaneously during the analysis.
For instance, NovoExpress Software enables scientists of all experience levels to acquire and analyze data efficiently. By automating many fluidic functions, the software eliminates time-sucking and cumbersome procedures. This software is flexible, intuitive, and versatile in nature. A CAGR of 6% is expected for this segment.
Why is Pharmaceutical & Drug Discovery Prominent Flow Cytometry Utilizer?
Drug discovery and development is a very complex, lengthy, and expensive process. As a tool to identify and characterize drug-induced toxicity in animal models and cell culture systems, flow cytometry has been used for a drug safety assessment with multiple benefits for biomedical research.
Flow cytometry allows measurement of acute or subacute toxic effects, as well as the detection of cancerous, mutational, and cancer-causing effects in tissue samples or cultured cells. These devices are used in preparing single-cell suspensions of tissue samples in a homogeneous or dissociated state, which allows the study of preclinical toxicity of drugs on any tissue sample. A market share of 45% is projected for this segment.
Strategic collaborations enable manufacturers to increase production and meet consumer demand which will increase revenue and market share. New products and technologies will enable end-users to benefit from products that are eco-friendly by nature.
- On February 17th, 2021, Thermo Fisher Scientific Inc. acquired the cell sorting technology assets of Propel Laboratories. As part of the agreement, Bigfoot Spectral, along with 40 employees, will be part of Thermo Fisher's Biosciences business. Propel Labs continues to operate separately and will remain focused on serving its existing customers.
- On August 12th, 2021, bioAffinity Technologies announced the development of sputum processing and high-throughput analysis methods. JoVE (Journal of Visualized Experiments) provides a detailed description of a technique that can swiftly identify diseases such as COPD, asthma, and lung cancer in sputum using flow cytometry. Additionally, the firm developed CyPath, a technology platform to detect cancer.
Have a report related query? Speak to us directly
Market size value in 2020
|USD 5.3 Billion|
Market forecast value in 2031
|USD 12.5 Billion|
|CAGR of ~9% from 2021 to 2031|
Historical Data Available for
|US$ Mn for Value & ‘000 Units for Volume|
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered
- Cell-based Flow Cytometry
- Bead-based Flow Cytometry
Products & Services
- Flow Cytometry Reagents & Consumables
- Flow Cytometry Instruments
- Flow Cytometry Software
- Flow Cytometry Services
- Flow Cytometry for Pharmaceutical & Drug Discovery
- Flow Cytometry for Diagnostics
- Flow Cytometry for Other Applications
- Flow Cytometry for Hospitals & Diagnostic Labs
- Flow Cytometry for Academic & Research Institutions
- Flow Cytometry for Other End Users
Flow Cytometry Market- Scope of Report
A recent study by Fact.MR on the flow cytometry market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering flow cytometry.
The study also provides the dynamics responsible for influencing the future status of the flow cytometry market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the flow cytometry market, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of flow cytometry across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of flow cytometry during the forecast period. Price point comparison by region with global average price is also considered in the study.
Key Questions Answered in Report
- Which are the most lucrative flow cytometry markets?
- Which factors will impact the growth of flow cytometry?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the flow cytometry industry?
- What are the winning strategies of stakeholders in the market?
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).
Estimates at global and regional levels for flow cytometry are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global flow cytometry market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of flow cytometry during the forecast period.
Country-specific valuation on demand for flow cytometry has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Analysis on Competition Analysis
The report sheds light on leading manufacturers of flow cytometry, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering flow cytometry has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the flow cytometry domain.
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the flow cytometry industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQs -
As of 2020, the flow cytometry market was valued at US$ 4.7 Bn according to Fact.MR
From 2016 to 2020, flow cytometry demand expanded at 8% value CAGR
From 2021 to 2031, the flow cytometry industry is expected to surge at 9% CAGR
According to Fact.MR, the flow cytometry value is expected to reach US$ 12.5 Bn by 2031
Unceasing research in developing robust immunotherapy approaches and mechanisms is driving flow cytometry demand
Major market players include Becton Dickinson & Company., Merck & Co. Inc., Beckman Coulter Inc., Thermo Fisher Scientific Inc. and SYSMEX CORPORATIONs
Flow cytometry services in North America are expected to yield 1/3rd of the revenue in the global market
Asia is expected to register a CAGR of 14% in the global market for flow cytometry
Flow cytometry demand is expected to capture 45% demand in the pharmaceutical & drug discovery industry
Flow cytometry software will be highly preferred, clocking a 6% value CAGR
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.